Published

The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidence

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Zenodo (CERN European Organization for Nuclear Research)
Date: 2026-01-26
Source: OpenAlex
DOI: 10.5281/zenodo.18375715
PubMed: Unavailable

Authors

Fernando Mora López Johynny Solís Solís Ekaterina Daniela Hernández Baker Olger Herrera Barboza David Diaz Polo Daniela Consumi Cordero

Watch author

Derived topics and classifications

psilocybin Depression Chronic Pain Neuroplasticity Brain Imaging Mechanism of Action Receptor Pharmacology Default Mode Network Biomarkers Aging Emotional Processing Clinical Trial Randomized Controlled Trial Review Article Treatment-Resistant Depression Safety Adverse Events Toxicity Randomized Controlled Trial

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidence2026-01-26

Related papers

Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric DisordersPsychiatry and Clinical Psychopharmacology · 2026-03-30 From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical PracticePharmacology Research & Perspectives · 2026-05-10 A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populationsTherapeutic Advances in Psychopharmacology · 2026-02-28 Psilocybin-induced neurocardiogenic syncope: a case reportPsychopharmacology · 2026-05-28 Editorial: Psychedelic substances and neurological diseases: from basics to clinical applicationFrontiers in Pharmacology · 2026-03-15 Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative reviewClinical Neuropsychopharmacology and Addiction · 2025-09-24 Psychedelics, entactogens and psychoplastogens for depression and related disorders.British journal of pharmacology · 2026-07-01 Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’Behavioural Pharmacology · 2026-05-06